Organised by the FIP Technology Advisory Group in collaboration with the FIP Regulatory Advisory Group, the FIP Ethics Advisory Group & the FIP Academic Pharmacy Section
Chair(s)
Dr Sini Eskola, European Federation of Pharmaceutical Industries and Associations (EFPIA) & Dr Rob Moss, FIP Bureau Member, the Netherlands
Introduction:
This session aims to discuss the role of remote monitoring technologies in enhancing clinical trial efficiency, the types of digital measures used (wearables, mobile apps, etc.), and the benefits of real-time data collection. It will explore the challenges in patient recruitment and adherence and regulatory considerations and will present case studies demonstrating the successful integration of remote monitoring in trials. The session will also look at future trends in digital measures for research, and their impact in patient enrolment and the validity of clinical trials.
Programme:
| 14:30 – 14:35 | Introduction by the chairs |
| 14:35 – 15:00 | Digital measures for research: impact on patient engagement and data validity |
| Prof. David A Hall, University of Arizona, USA | |
| 15:00 – 15:25 | Enhancing clinical trial efficiency with remote patient monitoring |
| Dr Amos de Jong, University of Utrecht, Netherlands | |
| 15:25 – 15:55 | Challenges and opportunities in implementing digital measures and monitoring in clinical trials |
| Speaker to be confirmed | |
| 15:55 – 16:00 | Wrap-up & closing remarks |
Learning objectives:
1. To learn how remote monitoring technologies, such as wearables and apps, enhance clinical trial efficiency and improve the quality of data collection.
2. To learn the benefits of digital measures in enhancing patient engagement and retention in trials, and their positive impact on data validity.
3. To discuss challenges in patient recruitment, adherence, and data management, and explore solutions.
4. To gain insights into regulatory and ethical aspects, including data privacy compliance.
Take home messages:
Remote patient monitoring and digital measures can revolutionise clinical trials by improving efficiency, patient engagement, and data accuracy. These technologies allow real-time data collection and enable more inclusive trials, addressing challenges such as patient recruitment and adherence. However, success depends on careful attention to regulatory compliance, data privacy, and the usability of digital tools. Involving patients in the design of these tools is crucial for ensuring that digital measures are both effective and user-friendly. By integrating these insights, clinical trials can become more sustainable, personalised, and adaptable to evolving healthcare needs, ultimately leading to better research outcomes and patient care.
